RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $53,301 | +56.8% | 35,534 | +22.2% | 0.00% | – |
Q3 2022 | $34,000 | -26.1% | 29,086 | +87.8% | 0.00% | – |
Q1 2022 | $46,000 | +76.9% | 15,487 | +34.5% | 0.00% | – |
Q4 2018 | $26,000 | -89.1% | 11,515 | -83.0% | 0.00% | -100.0% |
Q1 2018 | $239,000 | +368.6% | 67,550 | +236.1% | 0.00% | – |
Q3 2017 | $51,000 | -96.3% | 20,100 | -94.6% | 0.00% | -100.0% |
Q3 2016 | $1,376,000 | +3100.0% | 375,000 | +1842.6% | 0.01% | – |
Q2 2016 | $43,000 | -46.2% | 19,304 | -49.8% | 0.00% | – |
Q1 2016 | $80,000 | +73.9% | 38,464 | +151.0% | 0.00% | – |
Q4 2015 | $46,000 | -68.3% | 15,324 | -76.0% | 0.00% | -100.0% |
Q4 2014 | $145,000 | -87.9% | 63,773 | -89.7% | 0.00% | -88.9% |
Q3 2014 | $1,203,000 | -68.5% | 620,000 | -53.7% | 0.01% | -82.0% |
Q4 2013 | $3,813,000 | +7.2% | 1,338,036 | +34.6% | 0.05% | +4.2% |
Q3 2013 | $3,558,000 | +77.6% | 993,740 | +65.7% | 0.05% | +41.2% |
Q2 2013 | $2,003,000 | – | 599,711 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |